Nε-(Carboxymethyl)lysine levels in patients with type 2 diabetes: Role of renal function

American Journal of Kidney Diseases

Volumn 38, Issue 4, 2001, Pages 785-791

  Wagner, Zoltn ^a   Wittmann, Istvan ^a   Mazak, Istvan ^a   Schinzel, Reinhard ^a   Heidland, August ^a   Kientsch Engel, Rosemarie ^a   Nagy, Judit ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Advanced glycation end products (AGEs); Carboxymethyllysine; Diabetic nephropathy; Oxidative stress; Renal function

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; CREATININE; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; LIPOPROTEIN; DRUG DERIVATIVE; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; URINARY EXCRETION; BLOOD; MIDDLE AGED; OXIDATIVE STRESS; PATHOPHYSIOLOGY; URINE;

ADULT; AGED; AGED, 80 AND OVER; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYSINE; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 0034741275     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.27695     Document Type: Article

References (27)

1. Advanced protein glycosylation in diabetes and aging
2. Glycation and advanced glycation end products
3. Role of oxidative stress in diabetic complications
4. Accelerated age-related browning of human collagen in diabetes mellitus
5. Relationships between glycation and oxidation related fluorescence in rat collagen during aging - An in vivo and in vitro study
6. Advanced Maillard reaction products as markers for tissue damage in diabetes and uremia: Relevance to diabetic nephropathy
7. Biology of disease. Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging
8. Increased accumulation of the glycoxidation product Nε-(carboxymethyl) lysine in human tissues in diabetes and aging
9. Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients
10. Mechanisms for the formation of glycoxidation products in end-stage renal disease
11. Plasma levels of pentosidine in diabetic patients: An advanced glycation end product
12. Reactive glycosylation endproducts in diabetic uremia and treatment of renal failure
13. The pathogenesis and consequences of AGE formation in uraemia and its treatment
14. Prediction of creatinine clearance from serum creatinine
15. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA
16. Formation of plasma advanced glycation end products (AGEs) has no influence on plasma viscosity
17. Advanced glycation end products: Detection and reversal
18. Increased serum levels of pentosidine, but not carboxy-methyl lysine, in type 2 diabetes without obvious diabetic nephropathy
19. Immunological determination of advanced glycosylation end-products in human blood and urine
20. lc for the assessment of diabetic control
21. Increased serum levels of advanced glycation end-products and diabetic complications
22. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia
23. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis
24. Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells
25. Renal catabolism of advanced glycation end products: The fate of pentosidine
26. Effect of diabetes and aging on carboxymethyllysine levels in human urine
27. 99mTc-DTPA renogram is less precise than measured and predicted creatinine clearance